CHI Advisors as of Dec. 31, 2022
Portfolio Holdings for CHI Advisors
CHI Advisors holds 22 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 27.0 | $102M | 924k | 110.00 | |
| Pliant Therapeutics (PLRX) | 16.4 | $62M | 3.2M | 19.33 | |
| Vectivbio Hldg Ord Shs | 12.7 | $48M | 5.5M | 8.66 | |
| Repare Therapeutics Ord (RPTX) | 11.0 | $41M | 2.8M | 14.71 | |
| Cullinan Oncology (CGEM) | 9.3 | $35M | 3.3M | 10.55 | |
| Larimar Therapeutics (LRMR) | 3.8 | $14M | 3.5M | 4.13 | |
| Compass Therapeutics (CMPX) | 3.8 | $14M | 2.8M | 5.03 | |
| Kezar Life Sciences | 3.5 | $13M | 1.9M | 7.04 | |
| Keros Therapeutics (KROS) | 2.7 | $10M | 215k | 48.02 | |
| Omega Therapeutics Common Stock (OMGAQ) | 1.6 | $6.0M | 1.1M | 5.71 | |
| Rallybio Corp (RLYB) | 1.3 | $4.8M | 726k | 6.57 | |
| Ikena Oncology (IKNA) | 1.2 | $4.4M | 1.6M | 2.66 | |
| Precision Biosciences Ord | 1.1 | $4.2M | 3.5M | 1.19 | |
| 2seventy Bio Common Stock | 0.8 | $3.1M | 333k | 9.37 | |
| Orchard Therapeutics Spon Ads | 0.8 | $3.0M | 8.0M | 0.37 | |
| Inozyme Pharma (INZY) | 0.6 | $2.3M | 2.2M | 1.05 | |
| Freeline Therapeutics Hldgs Sponsored Ads | 0.6 | $2.3M | 4.8M | 0.48 | |
| Corvus Pharmaceuticals (CRVS) | 0.5 | $2.0M | 2.4M | 0.85 | |
| G1 Therapeutics | 0.5 | $1.8M | 334k | 5.43 | |
| Ovid Therapeutics (OVID) | 0.4 | $1.6M | 865k | 1.86 | |
| Oncorus | 0.2 | $600k | 2.4M | 0.25 | |
| Direxion Shs Etf Tr Daily S&p Biotec (LABD) | 0.1 | $431k | 25k | 17.25 |
